SCHEMBL4592496

SCHEMBL4592496

N#Cc1ccc(-c2ccc(CCCN)nn2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.50
MCHR1 Q99705 5/20 0.50
CHRM1 P11229 3/20 0.50
CASP1 P29466 1/20 0.39
NOTUM Q6P988 1/20 0.38
LOXL2 Q9Y4K0 1/20 0.37
MAOB P27338 2/20 0.37
KDM1A O60341 1/20 0.37
GABRA1 P14867 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
TSHR P16473 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GAA P10253 1/20 0.36
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15783689 0.85 CHRM1 (0.50) HTR2AMCHR1CHRM1MAOBTSHR
SCHEMBL4591798 0.83 ADRA2C (0.47) NOTUMMAOBKDM1AGABRA1GABRG2
SCHEMBL4591859 0.80 MCHR1 (0.48) HTR2AMCHR1CHRM1MAOBGAA
SCHEMBL4592777 0.80 LMNA (0.45) HTR2AMCHR1CHRM1NOTUMALDH1A1
SCHEMBL4592191 0.80 MCHR1 (0.48) HTR2AMCHR1CHRM1CASP1NOTUM
SCHEMBL4592094 0.78 MCHR1 (0.46) HTR2AMCHR1CHRM1CASP1LOXL2
SCHEMBL4592220 0.76 MCHR1 (0.55) HTR2AMCHR1CHRM1MAOBKDM4E
SCHEMBL5426112 0.76 CHRM1 (0.41) HTR2AMCHR1CHRM1GAA
SCHEMBL4592464 0.74 MAOB (0.38) HTR2AMCHR1CHRM1NOTUMMAOB
SCHEMBL9553392 0.73 HTR2A (0.44) HTR2AMCHR1CHRM1MAOBKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1943231-A1 (HETERO)ARYL COMPOUNDS WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-07-16 EP disclosed
US-20070111981-A1 New (hetero)aryl compounds with MCH antagonistic activity and medicaments comprising these compounds ROTH GERALD J 2007-05-17 US disclosed
WO-2007048802-A1 (HETERO)ARYL COMPOUNDS WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070111981-A1 New (hetero)aryl compounds with MCH antagonistic activity and medicaments comprising these compounds MCHR1, GPR119, MCHR2 HTR2A 66/4885MCHR1 1/4885CHRM1 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.